Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p14
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 14/22)
Character Range: 223254–226821

except:
 (a) when included in Schedule 2, 3 or 6; or
 (b) in preparations for dermal use for the treatment of tinea pedis.
# MIDAZOLAM.
MIDOSTAURIN.
MIDODRINE.
MIFEPRISTONE.
MIGALASTAT.
MIGLITOL.
MIGLUSTAT.
MILBEMYCIN OXIME except when included in Schedule 5.
MILNACIPRAN.
MILRINONE.
MINOCYCLINE.
MINOXIDIL except when included in Schedule 2.
MIRABEGRON.
MIRIKIZUMAB.
MIRTAZAPINE.
MISOPROSTOL.
MITOBRONITOL.
MITOMYCIN.
MITOTANE.
MITOXANTRONE.
MITRATAPIDE.
MIVACURIUM CHLORIDE.
MOBOCERTINIB.
MOCLOBEMIDE.
MODAFINIL.
MOLGRAMOSTIM.
# MOLIDUSTAT.
MOLINDONE.
MOLNUPIRAVIR.
MOMELOTINIB.
MOMETASONE except when included in Schedule 2 or Schedule 3.
MONENSIN except:
 (a) when included in Schedule 5 or 6; or
 (b) in animal feeds containing 360 mg/kg or less of antibiotic substances.
MONOBENZONE and alkyl ethers of hydroquinone for human therapeutic use or cosmetic use except in cosmetic nail preparations containing 0.02% or less of monobenzone or alkyl ethers of hydroquinone.
MONOCLONAL ANTIBODIES for therapeutic use except:
 (a) in diagnostic test kits; or
 (b) when separately specified in these Schedules.
MONOETHANOLAMINE in preparations for injection.
MONTELUKAST.
MOPERONE.
MORAZONE.
MORICIZINE.
MOTRAZEPAM.
MOTRETINIDE.
MOXIDECTIN in preparations for injection containing 10% or less of moxidectin except when included in Schedule 5 or 6.
MOXIFLOXACIN.
MOXONIDINE.
MUMPS VACCINE.
MUPIROCIN.
MURAGLITAZAR.
MUROMONAB.
MUSTINE (nitrogen mustard).
MYCOPHENOLIC ACID (includes mycophenolate mofetil).
NABUMETONE.
NADOLOL.
NADROPARIN.
NAFARELIN.
NAFTIDROFURYL.
NALBUPHINE.
NALIDIXIC ACID.
NALMEFENE.
NALORPHINE.
NALOXEGOL.
NALOXONE except when in Schedule 3.
NALTREXONE.
# NANDROLONE.
NAPROXEN except when included in Schedule 2 or 3.
NARASIN except:
 (a) when included in Schedule 6; or
 (b) in animal feeds containing 100 mg/kg or less of antibiotic substances.
NARATRIPTAN except when included in Schedule 3.
NATALIZUMAB.
NATAMYCIN except for use as a food additive.
NATEGLINIDE.
NEBACUMAB.
NEBIVOLOL.
NEBRACETAM.
NEDOCROMIL.
NEFAZODONE.
NEFIRACETAM.
NEFOPAM.
NELARABINE.
NELFINAVIR (includes nelfinavir mesilate).
NEOMYCIN.
NEOSTIGMINE.
NEPAFENAC.
NERATINIB.
NERIUM OLEANDER.
NESIRITIDE.
NETILMICIN.
NETUPITANT.
NEVIRAPINE.
NIALAMIDE.
NICARDIPINE.
NICERGOLINE.
NICOFURANOSE.
NICORANDIL.
# NICOTINE in preparations for human use except:
 (a) when included in Schedule 3; or
 (b) in preparations for oromucosal or transdermal administration for human therapeutic use when included in the Register as an aid in withdrawal either from tobacco smoking or nicotine vaping; or
 (c) in tobacco prepared and packed for smoking.
NICOTINIC ACID in preparations for:
 (a) human therapeutic use except:
  (i) when separately specified in these Schedules; or
  (ii) in preparations containing 100 mg or less of nicotinic acid per dosage unit; or
  (iii) nicotinamide; or
 (b) animal therapeutic use when packed and labelled for injection.
NICOUMALONE.
NIFEDIPINE.
NIFENAZONE.
NIKETHAMIDE.
NILOTINIB.
NILUTAMIDE.
NIMESULIDE.
NIMODIPINE.
NIMORAZOLE.
NINTEDANIB.
NIRAPARIB.
NIRIDAZOLE.
NIRMATRELVIR.
NIRSEVIMAB.
NISOLDIPINE.
NITISINONE.
# NITRAZEPAM.
NITRENDIPINE.
NITRIC OXIDE for human therapeutic use.
NITROFURANTOIN.
NITROFURAZONE.
NITROUS OXIDE for therapeutic use.
NITROXOLINE.
NIVOLUMAB.
NIZATIDINE except when included in Schedule 2.
NOMEGESTROL.
NOMIFENSINE.
NORADRENALINE.
# 19‑NORANDROSTENEDIOL.
# 19‑NORANDROSTENEDIONE.
# NORANDROSTENOLONE.
# NORBOLETHONE.
# NORCLOSTEBOL.
NORELGESTROMIN.
# NORETHANDROLONE.
NORETHISTERONE.
NORFLOXACIN.
NORGESTREL.
NORIBOGAINE.
NORMAL